GSA Capital Partners »

Monopar Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $697k 7.5k 92.54

More positions owned by GSA Capital Partners

Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Spdr Series Trust St Shor Corp Etf (SPSB)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Agree Realty Corporation (ADC)
Bank Ozk (OZK)
PNM Resources (TXNM)
Essential Properties Realty reit (EPRT)
TJX Companies (TJX)
Everest Re Group (EG)
O'reilly Automotive (ORLY)
American Airls (AAL)
Medtronic SHS (MDT)
Northrop Grumman Corporation (NOC)

View all positions for GSA Capital Partners

Top funds holding Monopar Therapeutics

Henderson Group
Jupiter Topco
RA Capital Management
BlackRock
Deerfield Management Company
Saturn V Capital Management
Siren
ADAR1 Capital Management
Polar Capital Holdings
Vanguard Capital Management
Adage Capital Partners GP
TCG Crossover Management
Wellington Management Company
OrbiMed Advisors
Candriam Luxembourg S.C.A.

View all funds holding Monopar Therapeutics